CanAm Wins USCIS Approval for Bellwether EB-5 Project

U.S. Citizenship and Immigration Services approved CanAm Enterprises’ Form I-956F for the Bellwether Innovation Campus EB-5 project in Philadelphia, clearing a key regulatory step for the life sciences facility tied to TerraPower Isotopes. The approval is CanAm’s 18th project greenlit under the EB-5 Reform and Integrity Act of 2022.

Why it matters: - USCIS approval of Form I-956F confirms the Bellwether Innovation Campus EB-5 project meets the requirements of the Regional Center Program under the EB-5 Reform and Integrity Act of 2022. - The approval clears a major milestone for an investment tied to a new life sciences manufacturing facility in Philadelphia. - CanAm now has 18 projects approved under the 2022 law, reinforcing its position in the EB-5 market.

What happened: - CanAm Enterprises said USCIS approved the Form I-956F for the Bellwether Innovation Campus EB-5 Project by letter dated Sept. 22, 2026. - The project centers on ground-up construction of a 253,180-square-foot build-to-suit advanced manufacturing life sciences facility for TerraPower Isotopes. - The facility will rise on an approximately 10-acre site inside the 1,300-acre Bellwether District in Philadelphia, Pennsylvania. - HRP Group is the developer. - The project’s $110.4 million EB-5 loan closed in June 2026.

The details: - Form I-956F is the USCIS application for approval of an investment in a commercial enterprise. - The approval signals that the project structure and investment meet EB-5 program requirements. - CanAm said the Bellwether project is its 18th Form I-956F approval under the EB-5 Reform and Integrity Act of 2022. - CanAm was founded in 1987 and has more than 20 years of experience in the U.S. EB-5 program. - CanAm says it has raised more than $4.1 billion in EB-5 capital for more than 75 projects and repaid more than $2.5 billion, including 53 projects repaid in full. - CanAm is headquartered in New York City and has offices in Beijing, Shanghai, Ho Chi Minh City, New Delhi and Singapore.

Between the lines: - The approval gives the project a regulatory green light, which can help reduce uncertainty for investors and development timelines. - The repeated approvals under the 2022 law suggest CanAm continues to move a large pipeline through USCIS review. - The Philadelphia project also shows continued EB-5 financing activity in specialized industrial and life sciences real estate.

What’s next: - Development work can continue with the USCIS approval in hand. - CanAm is likely to keep pursuing additional EB-5 project approvals as part of its broader program pipeline. - The Bellwether Innovation Campus project will move forward as a key life sciences build for TerraPower Isotopes in Philadelphia.

The bottom line: - USCIS approval removes a key hurdle for a $110.4 million EB-5-backed life sciences project in Philadelphia and extends CanAm’s run of approvals under the 2022 reform law.